Atypical Chemokine Receptor 1 (ACKR1), previously known as the Duffy Antigen Receptor for Chemokines, stands out among chemokine receptors for its high selective expression on Purkinje cells of the cerebellum, consistent with the ability of ACKR1 ligands to activate Purkinje cells in vitro. Nevertheless, evidence for ACKR1 regulation of brain function in vivo has been lacking. Here we demonstrate that Ackr1 −/− mice have markedly impaired balance and ataxia when placed on a rotating rod and increased tremor when injected with harmaline, a drug that induces wholebody tremor by activating Purkinje cells. Ackr1 −/− mice also exhibited impaired exploratory behavior, increased anxiety-like behavior and frequent episodes of marked hypoactivity under low-stress conditions. The behavioral phenotype of Ackr1 −/− mice was the opposite of the phenotype occurring in mice with cerebellar degeneration and the defects persisted when Ackr1 was deficient only on non-hematopoietic cells. We conclude that normal motor function and behavior depend in part on negative regulation of Purkinje cell activity by Ackr1.
INTRODUCTION
Atypical Chemokine Receptor 1 (ACKR1) is a new standardized name for the Duffy Antigen Receptor for Chemokines (DARC). A member of the 7-transmembrane (7TM) domain protein superfamily, ACKR1 is able to bind specifically to many pro-inflammatory chemokines; however, unlike typical 7TM proteins (but like other ACKRs), it is unable to signal through heterotrimeric G proteins (1) (2) (3) (4) . Some ACKRs have been shown to signal through arrestin-dependent pathways, but so far evidence of this is lacking for ACKR1 (5) .
Another unusual feature of ACKR1 is that, unlike other chemokine receptors, including other ACKRs, ACKR1 does not appear to be expressed on leukocytes; instead, it is expressed by erythrocytes, endothelial cells of post-capillary venules, and in the brain. On erythrocytes it was first identified as the Duffy Antigen, a polymorphic determinant of ACKR1 that defines the Fy blood group system (6, 7) . Erythrocyte ACKR1 is thought to scavenge chemokines, to both shape and buffer chemokine concentration gradients during inflammatory responses (8, 9) . In addition, in humans, erythrocyte ACKR1 is exploited for cell entry by Plasmodium vivax, a major cause of malaria, and red blood cell selective ACKR1-negative individuals with a mutation in the ACKR1 promoter are protected from this disease (10, 11) . On endothelial cells (12) , ACKR1 is thought to mediate transcytosis of chemokines for subsequent presentation to blood leukocytes (13) .
In human brain, ACKR1 is expressed specifically on cerebellar Purkinje neurons as demonstrated by immunohistochemistry (14, 15) . Likewise, in mouse brain, in situ hybridization data from the Allen brain atlas (16) and published PCR data (17) show that Ackr1 is expressed at highest levels in the cerebellum, and less so in other brain regions like olfactory bulb, parts of the cortex and hypothalamus (16) . Consistent with the expression data, Ackr1-binding chemokines have been reported to activate Purkinje cells in vitro. In particular, CCL2 induces Ca 2+ flux in rat Purkinje neurons (18) , and CXCL1 and CXCL8 induce Ca 2+ transients in mouse cerebellar slices (19) . CXCL2, which also binds to Ackr1 (20, 21) , seems to modulate neurotransmitter release in rat cerebellum by activating ERK in cerebellar granule cells (22) . In addition, rat Purkinje neurons respond to the chemokines CCL2, CCL5 and CCL11 (23) , all of which also bind to ACKR1 with high affinity (4) . A reasonable hypothesis is that these responses are mediated by cognate G protein-coupled chemokine receptors, but negatively regulated by ACKR1 through its known scavenging function.
Despite these advances, evidence for an actual biological role for ACKR1 in brain in vivo has been lacking since its brain expression was discovered in 1994. Ackr1 −/− mice were tested in several behavioral paradigms and reported to show normal performance (24) . In rare cases ACKR1 is also silenced in humans in all tissues, including brain, due to a premature stop codon in the ACKR1 open reading frame. No behavioral abnormalities, however, were described for these persons (25) . Since such patients are rare, however, it is difficult to examine them systematically for neurologic and behavioral abnormalities, and the knockout mouse behavioral analysis was limited in scope. Therefore, we decided to reinvestigate whether ACKR1 regulates central nervous system function in mice, using motor challenges (rotarod and Morris water maze) or experimental paradigms for the determination of gait, tremor and anxiety-like-or exploratory behavior (force plate actometer, elevated plus maze).
RESULTS

Ackr1 deficiency impairs balance and motor behavior on the rotarod
In rotarod experiments, the animal is subjected to a vestibulomotor challenge by being placed on a rotating cylinder suspended above a platform. Since deficits in motor coordination or balance, e. g. caused by defects in cerebellar function, result in impaired performance in this test (26) (27) (28) , and since Ackr1 is highly expressed in cerebellum, we hypothesized that rotarod performance would be impaired in Ackr1-deficient mice.
Consistent with this, in four independent experiments with non-littermates (three trials per mouse and different mice in each experiment), Ackr1 −/− mice fell off the rotarod 30-40% sooner than Ackr1 +/+ control mice that had been used for backcrossing (Figure 1A and B; p<0.001). To exclude effects by background mutations in other genes, we repeated the experiments with littermates of Ackr1 +/− X Ackr1 +/− crosses in six independent experiments with six trials per mouse and experiment (two days with three trials per mouse). In each experiment, different mice were used. Analysis of all data for all animals demonstrated that rotarod performance was significantly impaired in Ackr1 −/− mice on day 1 and in both Ackr1 +/− and Ackr1 −/− mice on day 2 ( Figure 1C ), pointing strongly to Ackr1 as the gene responsible for this phenotype. This appeared to be related to a slower rate of improvement with repeated trials of Ackr1 −/− mice compared to Ackr1 +/+ mice, which was particularly evident in trials 4 and 5 on day 2 ( Figure 1D ). Video analysis showed that Ackr1 −/− mice exhibited evidence of mild ataxia while on the rotarod (Suppl. movies 1 and 2). In particular, the Ackr1 −/− mouse is slower in stepping forward and the hind feet are carried lower relative to the rod axis, eventually losing their grip. Mice normally make occasional 180° turns relative to the vertical axis, which requires complex motor coordination. Table 1 shows a trend towards a reduced number of 180° turns in Ackr1 +/− -and Ackr1 −/− mice as compared to Ackr1 +/+ controls. Since the data were not normally distributed, we performed a nonparametric Kruskal-Wallis analysis, yielding a genotype effect close to significance for day 1 (p = 0.0594). A post-hoc nonparametric Mann-Whitney U test yielded a significant difference between Ackr1 +/+ and Ackr1 +/− mice on day 1 of the rotarod experiment (p = 0.0237). This result additionally points to impaired motor coordination of Ackr1 −/− mice.
Ackr1-deficiency reduces locomotion and promotes anxiety-like behavior on the elevated plus maze
The cerebellum may be involved not only in balance but also in emotional processes and anxiety (29, 30) . Therefore, we next tested the performance of Ackr1-deficient mice on an elevated plus maze, an apparatus designed to make mice choose between either avoiding a potentially harmful situation that induces anxiety or engaging their natural curiosity in explorative behavior. The apparatus consists of two narrow platforms mounted ~60 cm above the floor that intersect perpendicularly at their centers, forming a plus sign. Both arms of one platform have walls (the 'closed' arms or 'safe' space), whereas both arms of the other platform lack walls (the 'open' arms or 'risky' space). The animals are initially placed undisturbed in the center, and their movements are tracked (Figure 2A ).
Compared to Ackr1 +/+ mice, the total number of arm entries from the center was significantly lower for both Ackr1 +/− and Ackr1 −/− mice ( Figure 2B ). This was associated with reduced average running speed and reduced percentage of open arm entries for Ackr1 +/− mice, as well as significantly less time spent in the center for Ackr1 +/− and Ackr1 −/− mice ( Figure 2C-E) . The strongest effect of Ackr1 deficiency, however, was only apparent when full length open arm exploration was analyzed. Unlike wild type mice, both Ackr1 −/− and Ackr1 +/− mice rarely explored the full length of the open arms (Suppl. Figure  1 ). To quantitate this phenotype, we calculated the time spent beyond the midpoint of the open arms, highlighted in red in Figure 2A . Both Ackr1 +/− and Ackr1 −/− mice spent significantly less time in the outer half of the open arms than Ackr1 +/+ controls, consistent with heightened anxiety ( Figure 2F ).
Ackr1-deficiency reduces spontaneous locomotion but induces spontaneous anxiety likebehavior and worsens harmaline-induced cerebellar tremor
We next studied behavior under virtually unstressed conditions, where the mouse can freely explore its environment. We used a force plate actometer, a square platform mounted on highly sensitive force transducers capable of detecting force across the platform surface with a time resolution as high as 0.01 s. Male and female Ackr1 −/− , Ackr1 +/− and Ackr1 +/+ littermates were monitored in 30 min sessions. Neither the force exerted on the plate during running sequences nor the gait frequency was significantly different in Ackr1 +/− or Ackr1 −/− mice compared to Ackr1 +/+ controls ( Figure 3A and B). In contrast, wall rear duration was prolonged in both Ackr1 +/− and Ackr1 −/− mice ( Figure 3C ). Ackr1 deficiency was also associated with a significantly reduced percentage of total time spent in the platform center, an indicator of increased anxiety consistent with the elevated plus maze results ( Figure 3D ).
The actometer also revealed markedly reduced spontaneous locomotor activity in both Ackr1 +/− (p = 0.002) and Ackr1 −/− mice (p = 0.005) ( Figure 3E ). The difference was apparent at the start of the session and persisted throughout. Nevertheless, wild-type controls appeared to 'settle down' more than knockouts during the first 3 minutes, probably because they started at a much higher activity level. The Ackr1-dependent reduction in spontaneous activity was caused mainly by a markedly increased frequency of hypoactive events, defined as movement limited to a radius <15mm for at least 5s ( Figure 3F , Suppl. videos 3 and 4).
To determine whether Ackr1 might regulate Purkinje neuron function in vivo, we injected mice with 15 mg/kg of harmaline, a drug that specifically stimulates Purkinje neurons and deep cerebellar nuclei via excitation of climbing fibers originating from the inferior olivary nucleus. This results in whole-body tremor, and is used as a model of essential tremor (31) . Actometer recordings indicated that Ackr1-deficient mice had increased harmaline tremor intensity ( Figure 3G ) and frequency ( Figure 3H ), suggesting that Ackr1 modulates Purkinje neuron function in vivo.
Ackr1 deficiency does not affect acquisition learning and visual acuity in the Morris water maze apparatus
We next evaluated Ackr1-deficient mice in the Morris water maze apparatus, which tests learning, memory and spatial orientation, involving several brain regions, including hippocampus and cerebellum (28, 32, 33) . The animal is tasked to swim until it finds a submerged, invisible platform; safe harbor provides positive reinforcement promoting learning and memory (34) . This test was most useful for establishing that Ackr1 deficiency did not affect visual acuity, which can affect outcome from most behavioral tests, specifically from elevated plus maze, rotarod and the Morris water maze test itself. In particular, all mice were able to see the platform when it was elevated above the water surface in the center of the pool. Under these conditions all mice found the platform within a time span that was comparable with the swimming time on the last day of the acquisition learning phase (data not shown). Figure 4 summarizes results of three independent water maze experiments. There is high inter-experimental variability for most parameters, so the results of each experiment are also shown in Suppl. Figure 2 . The results for the distance swum to reach the platform were the most consistent. In particular, although no differences between Ackr1 −/− and Ackr1 +/+ mice were observed for this parameter during the acquisition phase in any of the three experiments ( Figure 4C , left part; Suppl. Figure 2C , G, K, left part), during reversal learning, Ackr1 −/− mice showed reduced swimming distance compared to Ackr1 +/+ controls in all three experiments ( Figure 4C , right part; p = 0.023; Suppl. Figure 2C , G, K, right part). Increased thigmotaxis behavior (tendency to swim near the wall of the tank, a measure of anxiety) was observed in Ackr1 −/− mice in the reversal learning phase of experiments 1 and 2, but not experiment 3 (Suppl. Figure 2D , H, L) . This reached statistical significance for the summarized data as shown in Figure 4D (right part; p = 0.04). Differences in swimming speed and latency to find the platform were only found in experiment 1 (Suppl. Figure 2 ). Learning the platform location was also tested in probe trials with the platform removed. Except for the first water maze experiment, where acquisition learning was impaired in Ackr1 −/− mice, all mice clearly preferred the quadrant where the platform had been located before (data not shown).
Behavior is regulated mainly by Ackr1 on non-hematopoietic cells
To determine whether hematopoietic or non-hematopoietic Ackr1, or both, regulate behavior, we generated radiation bone marrow chimeras. Six weeks after transplantation in both sexes, engraftment was ~100% when Ackr1 −/− bone marrow was transferred into irradiated Ackr1 +/+ recipients (Ackr1 −/− ➔Ackr1 +/+ ), and at least 80 % for the converse transfer (Ackr1 +/+ ➔ Ackr1 −/− ) ( Figure 5 ). Figure 1 for non-chimeric Ackr1 +/+ and Ackr1 −/− mice, matched chimeras made by transferring Ackr1 −/− donor bone marrow to irradiated Ackr1 −/− recipients (Ackr1 −/− ➔Ackr1 −/− ) fell off the rotarod much sooner than Ackr1 +/+ ➔Ackr1 +/+ chimeras ( Figure 6 ). Genotype-mismatched Ackr1 +/+ ➔Ackr1 −/− chimeras performed as poorly as Ackr1 −/− ➔Ackr1 −/− controls, whereas the reciprocally mismatched Ackr1 −/− ➔Ackr1 +/+ chimeras performed as well as Ackr1 +/+ ➔Ackr1 +/+ controls. Thus, impaired rotarod performance depends on Ackr1 deficiency on non-hematopoietic cells, not hematopoietic cells, consistent with effects of Ackr1 in irradiation-resistant brain cells ( Figure 6 ).
Consistent with the results shown in
A dependence of effects of Ackr1 on non-hematopoietic cells was also seen in three of the four parameters measured on the elevated plus maze (i.e., average running speed, total number of arm entries, and duration in the center) ( Figure 7 ). The fourth parameter, percentage of open arm entries, was reduced in all chimeras tested as compared to corresponding non-chimeric littermates (compare Figures 2E and 7D , and Suppl. Figure 3) , and no significant difference was detected between any of the groups. Unlike Ackr1 +/+ mice (Suppl. Figure 1 ), the majority of chimeric mice made from Ackr1 +/+ recipients, regardless of the donor bone marrow genotype, did not cross the midline of the open arm, indicating a generally increased state of anxiety, possibly attributable to irradiation (35) , making this assay non-informative for this parameter.
In actometer experiments, we observed similar differences in behavior between Ackr1 −/− ➔Ackr1 −/− and Ackr1 +/+ ➔Ackr1 +/+ chimeras as we had observed between nonchimeric Ackr1 +/+ and Ackr1 −/− controls for all six unchallenged behavioral parameters measured (compare Figure 3A -F with Figure 8A -F). For two of these (i.e., force range within run and wall rear duration), performance was the same or very similar between Ackr1 −/− ➔Ackr1 −/− and Ackr1 +/+ ➔Ackr1 +/+ chimeras ( Figure 8A , C). Not surprisingly then, genotype-mismatched Ackr1 +/+ ➔Ackr1 −/− and Ackr1 −/− ➔Ackr1 +/+ chimeras performed similarly in these two parameters to each other and to both matched chimera controls ( Figure 8A , C). A relatively large difference in behavior was observed between Ackr1 −/− ➔Ackr1 −/− and Ackr1 +/+ ➔Ackr1 +/+ chimeras as measured by the other four unchallenged parameters (gait rhythm, % of time spent in center, distance moved, and hypoactive events) (Figure 8 B, D-F). Like the rotarod and elevated plus maze tests, Ackr1 +/+ ➔Ackr1 −/− chimeras tended to perform most like Ackr1 −/− ➔Ackr1 −/− controls, whereas the reciprocally mismatched Ackr1 −/− ➔Ackr1 +/+ chimeras performed most like Ackr1 +/+ ➔Ackr1 +/+ controls (Figure 8 B, D-F), suggesting that non-hematopoietic Ackr1 is important in regulating these behaviors, whereas hematopoietic Ackr1 is not.
With regard to the two parameters measured on the actometer after harmaline challenge, the intensity and frequency of harmaline-induced tremor, irradiation and bone marrow transfer attenuated both in chimeric mice compared to non-chimeric control mice (compare Figure  3G -H with Figure 8G -H). Nevertheless, tremor intensity was still significantly increased in Ackr1 −/− ➔Ackr1 −/− chimeras compared to Ackr1 +/+ ➔Ackr1 +/+ chimeras, phenocopying non-chimeric control mice ( Figure 8G ). Ackr1 +/+ ➔Ackr1 −/− and Ackr1 −/− ➔Ackr1 +/+ genotype-mismatched chimeras both had a low tremor phenotype similar to Ackr1 +/+ ➔Ackr1 +/+ chimeras, suggesting that both hematopoietic and non-hematopoietic Ackr1may contribute to this phenotype ( Figure 8G ).
Ackr1 deficiency does not affect macroscopic brain anatomy
The brain of the Ackr1 knockout mouse has been reported to be macroscopically normal and there were no histological differences detected (24) . However, since behavioral phenotypes had not previously been identified in this mouse, we decided to revisit this question. Using magnetic resonance imaging with brains from non-littermate Ackr1 +/+ -and Ackr1 −/− mice, we observed no difference in cerebellar size between Ackr1 +/+ and Ackr1 −/− mice, confirming the previous report (24) (Suppl. Figure 4 A, B) . A comparison of individual brain slices across the entire brain also found no difference, except in the dorsal part, where Ackr1 −/− brain appeared slightly smaller (Suppl. Figure 4C ). However, we cannot exclude the possibility that this may be caused by respiration-induced motion artifacts in this region, which contains the brain stem.
DISCUSSION
In this study, we report the first evidence that the atypical chemokine receptor Ackr1 regulates central nervous system function in vivo. Combined results from genetic, immunologic and pharmacologic analysis using Ackr1 −/− mice, radiation chimeric mice, and the tremor-inducing drug harmaline all point to the cerebellum, and in particular Purkinje cells, as the key site of Ackr1 action in vivo. This is consistent with previously published results demonstrating selective very high expression of Ackr1 in cerebellum, specifically on Purkinje cells (14) (15) (16) , which are known to respond to Ackr1 ligands in vitro (4, 18, 19) .
Our results disagree with Luo et al, who had previously reported that Ackr1 deficiency did not affect performance in 15 different behavior paradigms, including two that we used (water maze and rotarod) (24) . This group used an independently derived line of Ackr1 −/− mice to obtain these negative results, and did not specify the experimental conditions, which could have differed substantially from ours and affected the outcome. Moreover, we used two additional tests, including 'time spent in the terminal half of the opens arms' on the elevated plus maze test, which is a highly sensitive measure of anxiety-like behavior, and the actometer, which allows highly sensitive digital analysis of mouse motion. Finally, we verified the phenotypes we discovered using three complementary types of mouse breeding paradigms (backcrossed, littermates and radiation chimeras).
Of the eighteen parameters measured across the four types of apparatus used in our study (one for the rotarod, five for the elevated plus maze, four for the Morris water maze and eight for the actometer), Ackr1 −/− performance was abnormal (different from Ackr1 +/+ ) in twelve. Four of the twelve were designed to measure anxiety-like behavior, although not specifically for the cerebellum, and the performances of the knockout mice were consistent with an increase in this behavioral state (restricted exploration of the terminal half of the open arms on the elevated plus maze, increased thigmotaxis in the Morris water maze, and decreased time spent in the center of the actometer and the elevated plus maze). The remaining eight parameters were used to measure locomotor activity and motor coordination in various ways, and the performances of the knockout mice were decreased in all eight. Of these eight, three (time on the rotarod, and harmaline-induced tremor intensity and frequency) are most clearly related to cerebellar function, where Ackr1 is highly expressed.
Impaired rotarod performance was unlikely to be caused by impaired vision, since visual testing of the knockouts in the Morris water maze was normal, or by impaired motor learning, since after the sixth rotarod session Ackr1 −/− and Ackr1 +/+ mouse performance was the same. Moreover, it is unlikely that muscle weakness was responsible for reduced rotarod performance in Ackr1-deficient animals, because Ackr1 +/− -and Ackr1 −/− mice did not show a significantly reduced force range within run as compared to Ackr1 +/+ mice ( Figure 3A) . More likely contributing factors include ataxia, general hypoactivity, and increased anxiety.
Ataxia was directly observed on the rotarod rotarod, which represents a rather complex vestibulomotor challenge, whereas the virtually unchallenging actometer conditions revealed only a non-significant trend towards reduced gait frequency and running force. Hypoactivity was apparent in Ackr1 −/− mice in five tests not specifically designed to interrogate cerebellar function, three on the actometer (wall rear duration, number of hypoactive events and distance moved) and two on the the elevated plus maze (running speed and total number of arm entries), and has previously been discussed as an explanation for poor rotarod performance by the R6/2 mouse model of Huntington's disease (36) (36, 37) . However, wall rear duration is also used as a measure of non-selective attention in animal models of attentiondeficit hyperactivity disorder (38) . Defects in both motor systems and cognitive functions could contribute to this phenotype.
The harmaline experiments provide the most direct in vivo evidence of Ackr1 action in the cerebellum. Harmaline is a β-carboline alkaloid that specifically stimulates rhythmic firing of neurons in the inferior olive (IO) of the brainstem. Each IO neuron projects onto a Purkinje cell via a "climbing fiber". Purkinje neurons in turn connect to neurons of the deep cerebellar nuclei (DCN) that mediate cerebellar output. Some DCN neurons project back to the IO in an inhibitory way, resulting in a closed IO-, Purkinje-and DCN-neuron regulatory loop (39) . The DCN represents the only output of the cerebellum and is indispensable for harmaline-induced tremor, projecting the harmaline-induced firing pattern from IO-to cerebellar Purkinje neurons (31) . Mice with Purkinje cell degeneration (PCD mice) still express harmaline tremor, but with reduced intensity and frequency compared to wild-type controls (31, 40) , suggesting that Purkinje neurons are not required for harmaline tremor (31), but modulate it. Our results obtained with Ackr1 −/− mice suggest that Ackr1 on Purkinje neurons may alter tremor output from the DCN, probably by modulating Purkinje cell activity. Our results therefore point to an inhibitory effect of Ackr1 on the cerebellar output of harmaline-induced tremor, which will be discussed below.
The six parameters that were not clearly abnormal in Ackr1 −/− mice include three on the water maze (latency and distance to find the platform, and swimming speed), and two on the actometer that were previously discussed (gait rhythm and force range within run). Due to poor reproducibility, the data from the water maze tests should be interpreted with caution. Ackr1 −/− mice appeared to perform better than controls in the reversal learning paradigm, as indicated by decreased distance swum to find the platform in the reversal learning phase. Since acquisition learning was not influenced by Ackr1-deficiency, Ackr1 might affect behavioral flexibility and adaptation to new environmental conditions. A weak gene dosage effect can be seen in the rotarod results ( Figure 1 ) and in some of the actometer data ( Figure 3A, D, H) , resulting in an intermediate phenotype of Ackr1 +/− mice as compared to Ackr1 −/− animals and Ackr1 +/+ controls. In most cases, however, the behavior of Ackr1 +/− mice was similar to the behavior of full knockouts. Thus, maximum Ackr1 expression is required to reconstitute wild-type behavior.
Bone marrow chimera experiments revealed that most behavioral phenotypes were fully determined by the Ackr1 genotype of the recipient mouse. Thus, we conclude that these phenotypes are due to Ackr1 deficiency on Purkinje cells and possibly neurons from other brain regions. A moderate effect of donor genotype in Ackr1 +/+ ➔Ackr1 −/− mice reached significance only for the percentage of time spent in the center and for the number of hypoactive events (actometer, Figure 8 D, F) as well as for average running speed (elevated plus maze, Figure 7A ), suggesting a limited contribution of hematopoietic Ackr1. The Ackr1 −/− ➔ Ackr1 +/+ bone marrow chimeras imitate the situation in malaria-resistant Ackr1-negative humans (11) that selectively lack Ackr1 on red blood cells, while receptor expression is maintained in other tissues, e.g. vascular endothelium (41) . No psychological or behavioral abnormalities have been described for these persons, which is consistent with the absence of a behavioral phenotype in our Ackr1 −/− ➔ Ackr +/+ bone marrow chimeras.
Importantly, most of the behaviors we found to be abnormal in the Ackr1 −/− mouse, even anxiety-like behavior, have also been reported to be abnormal in one or more of three wellknown mouse models of selective cerebellar degeneration: the Lurcher mouse (Lc/+), the Purkinje cell degeneration mouse (pcd/pcd) and the "nervous" mouse (nr/nr) ( Table 2 ). All three models lose Purkinje neurons almost completely and -depending on the mutationundergo degeneration of other cerebellar regions and other types of neurons like the granular or molecular layer (28, 30, 42, 43) . Thus, it is plausible that Ackr1 deficiency in cerebellum, and not in other brain regions where it is expressed, accounts for most if not all of the behavioral phenotypes in Ackr1 −/− mice. However, interestingly, the behavioral phenotypes in these three cerebellar degeneration models are mostly the opposite of the corresponding phenotypes in Ackr1 −/− mice. Only rotarod performance was impaired in all four mutant mice (28, 44, 45) . A reasonable hypothesis to explain these results is that Ackr1 functions on neurons, as it does on erythrocytes, as a negative regulator, so that its loss increases cerebellar function, leading to the opposite phenotype as in the selective cerebellar degeneration mutants. Mechanisms of negative regulation could include scavenging of chemokines that act at G protein-coupled chemokine receptors on neurons, alternative signaling by neuronal Ackr1 in response to cognate chemokines produced by neurons and/or microglial cells, even signaling or scavenging by Ackr1 after binding non-chemokine ligands, including known neurotransmitters. Alternatively, Ackr1 could present chemokines to signaling receptors on neurons. The levels of free chemokines in blood and cerebellum may be governed by a balance of binding to Ackr1, dissociation from Ackr1 and by the rate of chemokine metabolism.
Additional work will be needed to test each of these possibilities. However, there are already reports indicating that pieces of the model are in place and that Ackr1-binding chemokines directly stimulate cerebellar Purkinje neurons, which motivated our work. In particular, Purkinje neurons, in addition to expressing Ackr1, express the Ackr1-binding chemokine CCL2 and its receptor CCR2, as well as receptors for the Ackr1-binding chemokines CCL5 and CCL11 (18, 23, 46) ; CCL2 has been reported to induce Ca 2+ flux in isolated rat Purkinje neurons (18) ; the Ackr1-binding chemokine CXCL8 causes Ca 2+ transients and enhances neurotransmitter release in mouse cerebellar slices (19) ; and CXCL2, which also binds to Ackr1 (20) , causes ERK activation and modulates neurotransmitter release in rat cerebellum (22) . In addition, brain mast cells are active under basal non-inflammatory conditions (47) and can release chemokines, including the Ackr1 ligands CCL2 and CCL5 (48) . Moreover, blockade of central mast cell activation has been reported to be associated with increased anxiety-like behavior in mice (49) , indicating another link between behavior and immune function. Astrocytes and microglial cells also express chemokines, including Ackr1 ligands (50) . Another level of potential complexity is added by the ability of Ackr1 to influence signaling of other chemokine receptors like CCR5 by forming hetero-oligomers (51) . It is intriguing to consider that Ackr1 might also interact in a chemokine-dependent manner with neurotransmitter receptors on Purkinje neurons and therefore modulate "classic" neurotransmitter responses.
In summary, our results demonstrate that Ackr1 plays an important role in regulating the central nervous system at the level of motor function and behavior. As indicated by our MRI results, Ackr1 deficiency does not result in gross abnormalities of the cerebellum and other brain regions, but rather seems to affect neurotransmission and activity of Purkinje neurons. In addition to neuropeptides and neurotransmitters, chemokines may in fact represent a "third major system of communication in the brain" (52) . To our knowledge, this is the most detailed behavioral characterization available for a chemokine receptor-deficient mouse. Our results provide a starting point for deeper investigation of the role of chemokines in the modulation of cerebellar function and -via cerebellar projections -of other brain areas.
Methods
Laboratory animals
Ackr1 −/− mice generated as previously described (8) were backcrossed at least 10 generations to C57Bl/6 mice, strain 664 (Jackson Laboratories, Woods Hole, MA) and, unless otherwise indicated, were bred in the same facility. Except for littermates, mice were housed separately by genotype, a maximum of five mice per cage; all mice were maintained at 22°C on a 12-h light/dark cycle (lights off at 6 pm). Mice were transferred to the behavior laboratory at least one week prior to the experiment, and tested between 10 am and 5 pm. Except for radiation chimeras, whose ages were heterogeneous, the groups were agematched with a maximum difference of two weeks. All experiments complied with guidelines set by the NIAID Animal Care and Use Committee (NIH).
Rotarod Experiments
Three to five month old mice were tested on one-or five-station rotarods (MedAssociates, St. Albans, VT, USA) from 12-6 pm. Each experiment involved two training sessions and 1-2 test sessions. Training session 1 consisted of a habituation trial on a stationary rod and three trials at 4 rpm, each lasting 60 s, with 45 seconds rest in between. 24 h later, training session 2 began, consisting of 3 trials in which the rod accelerated from 4 to 16 rpm within 100 seconds, with 100 seconds rest in between. The test session began 24 hours later, and consisted of three acceleration trials (4 to 40 rpm over 300 seconds) with 5-10 minutes rest in between. The endpoint was defined to occur when the mouse fell off the rotarod and disrupted an infrared beam. If animals started to cling to the rod to rotate passively, specifically at higher rotarod speeds, we did not intervene, but waited for the animals to fall off the rod. In littermate experiments, the test session was repeated 24 h later with the same animals, but in reversed order to avoid circadian rhythm effects. The frequency of 180° turns made on the rotarod relative to vertical was calculated by dividing the mean number of turns by the mean trial duration for each individual animal and experimental day. All experiments were performed at full illumination. The rotarod was cleaned between trials.
Elevated Plus Maze Experiments
3-4 month old mice were tested once for 5 min on a plus sign-shaped maze with two open and two closed arms situated 60 cm above the floor and illuminated at 60-75 lux in the center. Each arm is 30 cm long and 5 cm wide. The mouse is placed in the center (5 × 5 cm) and allowed to freely explore the maze. Movements were recorded using an Ethovision video-tracking system (Noldus, Wageningen, Netherlands). The maze was cleaned, if necessary, with 70% ethanol. The experiment followed the rotarod experiment during which the mice got habituated to an "out of cage" experience.
Actometer Experiments
Development of the force-plate actometer has been previously described in detail (53) . In brief, the actometer consists of a force-sensing plate (42 × 42 cm) mounted on force transducers in the four corners, which establish the location of the center of mass of the animal. The system produces a signal that depends on the weight and movements of the animal exploring the space. An enclosure suspended 2 mm above the surface confines the animal. Mice were placed in the center and allowed to freely explore the plate. Measurements were made for 30 min at an illumination of ~45 lux during the light phase between 10 am and 6 pm at a time resolution of 100 Hz and a force resolution of 0.2 gramforce, and were also recorded using a digital camera. The actometer was cleaned between sessions with 70% ethanol.
Locomotor activity was determined by calculating the distance moved during a session, based on the smoothed force variations (moving average of 9 data points). 'Hypoactive events' were defined as movement within a radius of <15 mm for at least 5 s. The percentage of time spent in the center was defined as the time spent in the central square that occupies 6% of the force plate area.
Within run force range and gait rhythm were determined from "long runs", defined as periods of lateral movements over a distance of 20 cm or more within a time frame of 2 s, following an almost straight line between starting and ending points. Straightness of the trajectory was evaluated by analysis of the obtuse angle of a triangle formed by a straight line connecting starting and ending point and the two segments from starting point to the middle and from ending point to the middle. An obtuse angle of 180° would mean a totally straight line. The run was included in the analysis if the obtuse angle was greater than 160°.
For the determination of wall rear number and duration, the raw data of the force variations were smoothed (moving average of 9 data points), transformed to percent of body weight and the mean (100%) was subtracted. Wall rears were defined as an off-load force between 5% and 40%, lasting at least 0.25 s. This discriminates wall rears from jumps (maximum off-load force 100%) and locomotion (off-load force between 30% and 90%, but shorter duration than 0.25 s).
Harmaline-induced tremor was investigated using ~5 month old Ackr1 −/− and Ackr1 +/+ littermates. First, PBS buffer was injected (5 ml/kg i.p.) followed immediately by a 30 min actometer session. 10-24 days later, the same animals were injected i.p. with 15 mg/kg harmaline (3 mg/mL in PBS) and again immediately monitored on the actometer for 30 min. Sessions were not performed after 5 pm to avoid any change of behavior from anticipating the dark phase. For the quantitation of harmaline tremor intensity and frequency, the raw data (expressed as percent of body weight with offset removed and after application of the Hanning data window) were converted to power spectra by a Fourier transformation (MatLab). The power spectra were calculated for each 10-s time frame of the recording session. Then the twelve 10-s frames with the highest peak power between 8 and 18 Hz were chosen for each mouse and averaged together, resulting in the maximum tremor exhibited by each individual mouse. This method was used to exclude "silent" periods that occur between bouts of harmaline tremor expression. From the resulting average power spectrum for each individual animal the parameters "peak power" and "frequency at peak" were calculated and subjected to statistical analysis.
For characterization of the mice in the bone marrow transfer experiments, experiments with PBS-and harmaline injection were performed essentially as described above, but observation time was reduced to 20 min, starting at 10 min after PBS-or harmaline injection. Since the maximum of the harmaline tremor is not reached before 10 min postinjection, the shortening of the time does not affect the harmaline tremor data calculated from the peak tremor.
Water Maze Experiments
The water-maze consists of grey PVC and has a diameter of 100 cm and a height of 45 cm. The water is kept at ~22°C and is stained with non-toxic white paint to increase contrast and rendering it opaque. Lights were covered to eliminate reflections. If unsuccessful, the mouse is placed on the platform for 10 s to foster learning. After each trial, the mice are dried with a paper towel under a heat lamp. Visual orientation prior to release into the pool is prevented using a non-transparent box to transport mice to the water maze. On the day following the 7-day acquisition phase, a probe trial is performed, during which the platform is removed from the pool and each mouse is placed in the pool for 60 s. (3) Reversal learning phase: the day after the acquisition test, the platform is moved to a different position and kept there for the following 4 days. During this time, the mice are tested according to the same protocol as described for the acquisition learning phase. Then, the platform is removed for a second probe trial. (4) Visual cue test: immediately after the reversal test, the hidden platform is raised above the water surface in the center of the pool. Two visual cue tests were performed to let the mice find the visible platform. Swim paths were recorded using an Ethovision video-tracking system (Noldus, Wageningen, Netherlands). For the acquisition and reversal phases the variables recorded were latency to reach the platform, mean swimming speed, swim path distance as well as percentage of the total time spent along the edge of the water maze (% thigmotaxis time). For the probe trials, the variables recorded were time to swim to the prior location of the hidden platform (latency), number of crossings (frequency) over the prior location of the hidden platform, time spent in the vicinity (quadrant of the circular pool) where the platform had been located, number of entries into the quadrant where the platform had been located, and mean swim speed.
Magnetic Resonance Imaging (MRI)
All studies complied with the guide for the care and use of Laboratory Animal Resources (1996), National Research Council, and approved by the National Institute of Neurologic Diseases and Stroke (NIH) Animal Care and Use Committee. Mice were anesthetized (1.5% isofluorane), and body core temperature was maintained and monitored at 37°C with a heated circulating water pad. A pressure transducer was positioned to monitor respiration. Mice were then placed in a stereotaxic holder and mounted in a 72 mm volume (transmit)/ 25 mm surface (receive) radio frequency coil ensemble for MRI. The MRI experiments were performed on a horizontal bore 7 Tesla scanner operating on a Bruker Avance platform (Bruker Biospin Inc. Bellerica, MA). Three mutually perpendicular scout images were acquired through the brain to localize the brain. , total imaging time 32 minutes) were acquired using a spin-echo pulse sequence to delineate anatomical details. For data analysis, T 2 weighted images were displayed slice by slice and regions of interests were drawn to calculate the area of the brain using Image J.
Generation of Bone Marrow Chimeras
Recipient mice were γ-irradiated with 900 Rad in the morning and were reconstituted with 5 × 10 6 donor bone marrow cells in 200 µl buffer (isolated during the five hours after irradiation) 6-8h after irradiation via tail vein injection. Recipients then received trimethoprim-sulfamethoxazole in autoclaved water for 4 weeks. Recipient and donor mice were 2-4 months old at the time of bone marrow transfer. Nineteen males (5 Ackr1 +/+ ➔ Ackr1 +/+ , 4 Ackr1 +/+ ➔ Ackr1 −/− , 5 Ackr1 −/− ➔ Ackr1 +/+ , 5 Ackr1 −/− ➔ Ackr1 −/− ) and 21 females (5 Ackr1 +/+ ➔ Ackr1 +/+ , 6 Ackr1 +/+ ➔ Ackr1 −/− , 5 Ackr1 −/− ➔ Ackr1 +/+ , 5 Ackr1 −/− ➔Ackr1 −/− ) were used. Blood genotyping was performed at ~6 weeks after bone marrow reconstitution to assess the extent of engraftment. Rotarod and elevated plus maze experiments with bone marrow chimeras were performed ~8 weeks after reconstitution. Actometer experiments were performed at ~9 weeks (PBS control experiment) or ~13 weeks (harmaline experiment) after reconstitution.
Genotyping
Ear punches were incubated for 2 h at 55°C in 50 µl lysis buffer (100 mM Tris-HCl [pH 8.0], 100 mM NaCl, 10 mM EDTA [pH 8.0], 0.2 % SDS and 0.8 mg/ml proteinase K). Samples were vortexed, diluted with 450 µL of DEPC-treated water, then centrifuged for 6 min at 7500 rpm.
Genotyping was performed with a three primer system:1) SCP440 (5'-GTCTAGCCCTGCACATACC-3'), 2) DARCneo (5'-TATGGCGCGCCATCGATCTC-3') and 3) DuffyCommon (5'-CCAGTAGCCCAGGTTGCATA-3'). 2 µl of ear punch extract were added to 23 µl of Platinum PCR Supermix™ (Life Technologies, Carlsbad, CA) containing 200-500 nM primers and amplified by PCR as follows: 3 min at 94°C, followed by 34 cycles of 30 s at 94°C, 30 s at 60°C, and 35 s at 72°C, followed by 7 min at 72 °C. Wild type and gene-targeted amplicons were 452 and 300 bp, respectively.Genotyping of chimeras was performed from blood drawn ~6 weeks after BMT. DNA was purified from 100 µl of blood (diluted with 100 µl PBS buffer) using the QiaAMP DNA blood mini kit™ (Quiagen, Hilden, Germany). Percentage of engraftment was determined by comparison with calibration samples generated from mixtures of wild-type and Ackr1 −/− blood containing 0, 20, 40, 60, 80 and 100 % wild-type blood.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. Characterization of spatial learning of Ackr1 +/+ and Ackr1 −/− mice in the Morris water maze. (A) Latency to find the platform; (B) swimming speed; (C) swimming distance covered until the platform is found and (D) thigmotaxis time (time spent close to the edge of the water maze). Curves were compared by 2-way ANOVA with separate analyses for acquisitionand reversal learning phase. Summary data for all animals tested are presented as the mean +/− SEM. P-values are given in the graphs. Rotarod performance of radiation bone marrow chimeras (male and female mice). Mice were tested on two consecutive days with three trials perday per animal. The groups are shown below the x-axis (donor ➔ recipient). Each symbol represents a single mouse. Bars represent means ± SEM of the average times spent on the rotarod during three independent trials for each mouse on each day; the same mice were tested on day 1 and day 2; n=10 mice for each condition. Groups were compared by 1-way ANOVA with Newman-Keuls post test; * indicates significance in comparison to the Ackr1 +/+ ➔Ackr1 +/+ group; + indicates a significant difference to Ackr1 −/− ➔Ackr1 −/− ; one symbol: p<0.05; two symbols: p<0.005; three symbols: p<0.001. 
